10
Nov

News

,
Diamond Biofund > 2025 > The Company’s 2025Q3 financial statements have been approved by the Board of Directors

Major Announcements by Year

2025-11-10

The Company’s 2025Q3 financial statements have been approved by the Board of Directors

分享
No 1 Date of announcement 2025/11/10 Time of announcement 19:01:19
Subject The Company’s 2025Q3 financial statements have been approved by the Board of Directors
Date of events 2025/11/10 To which item it meets paragraph 31
  1. Date of submission to the board of directors or approval by the board of directors:2025/11/10
  2. Date of approval by the audit committee:2025/11/10
  3. Start and end dates of financial reports or annual self-assessed financial information of the reporting period (XXXX/XX/XX~XXXX/XX/XX): 2025/01/01~2025/09/30
  4. Operating revenue accumulated from 1/1 to end of the period(thousand NTD):(1,089,714)
  5. Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):(1,089,714)
  6. Net operating income (loss) accumulated from 1/1 to end of the period(thousand NTD):(1,199,266)
  7. Profit (loss) before tax accumulated from 1/1 to end of the period(thousand NTD):(1,159,186)
  8. Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):(1,160,104)
  9. Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):(1,160,104)
  10. Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):(1.36)
  11. Total assets end of the period (thousand NTD):9,394,805
  12. Total liabilities end of the period (thousand NTD):168,322
  13. Equity attributable to owners of parent end of the period (thousand NTD):9,226,483
  14. Any other matters that need to be specified:None